We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
-0.57%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$19.1B
AUM Growth
-$71.6M
Cap. Flow
+$375M
Cap. Flow %
1.97%
Top 10 Hldgs %
20.96%
Holding
1,713
New
9
Increased
554
Reduced
98
Closed
38

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$83.2M
2
DQ
Daqo New Energy
DQ
+$42.7M
3
DAR icon
Darling Ingredients
DAR
+$33M
4
TER icon
Teradyne
TER
+$25.8M
5
IQV icon
IQVIA
IQV
+$25.1M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$49.3M
2
ALB icon
Albemarle
ALB
+$38.8M
3
FSLR icon
First Solar
FSLR
+$27.7M
4
NUAN
Nuance Communications, Inc.
NUAN
+$25.1M
5
JCI icon
Johnson Controls International
JCI
+$19.2M

Sector Composition

Rank Sector Weight
1 Technology 24.47%
2 Healthcare 17.68%
3 Consumer Discretionary 14.03%
4 Financials 13.08%
5 Industrials 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NGM
1651
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$210K ﹤0.01%
+10,000
New +$220K
PTVE
1652
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$207K ﹤0.01%
16,500
– –
CCXI
1653
DELISTED
ChemoCentryx, Inc.
CCXI
$207K ﹤0.01%
12,100
– –
AXSM icon
1654
Axsome Therapeutics
AXSM
$11.5B
$204K ﹤0.01%
6,200
– –
ATRI
1655
DELISTED
Atrion Corp
ATRI
$204K ﹤0.01%
+293
New +$195K
VVNT
1656
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
$199K ﹤0.01%
21,100
– –
KYNB
1657
Kyntra Bio
KYNB
$28.5M
$196K ﹤0.01%
768
– –
ICPT
1658
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$196K ﹤0.01%
13,165
– –
ENDP
1659
DELISTED
Endo International plc
ENDP
$194K ﹤0.01%
60,015
– –
HTLD icon
1660
Heartland Express
HTLD
$976M
$189K ﹤0.01%
11,816
– –
RDUS
1661
DELISTED
Radius Health, Inc.
RDUS
$186K ﹤0.01%
15,023
– –
BNGO icon
1662
Bionano Genomics
BNGO
$13.3M
$167K ﹤0.01%
51
– –
DCH
1663
Dauch Corp
DCH
$1.58B
$158K ﹤0.01%
17,946
– –
IBRX icon
1664
ImmunityBio
IBRX
$8.13B
$156K ﹤0.01%
16,000
– –
AERI
1665
DELISTED
Aerie Pharmaceuticals
AERI
$149K ﹤0.01%
13,051
– –
SDC
1666
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$145K ﹤0.01%
27,200
– –
ANGI icon
1667
Angi Inc
ANGI
$180M
$141K ﹤0.01%
1,140
– –
WKHS icon
1668
Workhorse Group
WKHS
$33.4M
$133K ﹤0.01%
6
– –
ARR
1669
Armour Residential REIT
ARR
$2.37B
$126K ﹤0.01%
2,340
– –
EPZM
1670
DELISTED
Epizyme, Inc
EPZM
$120K ﹤0.01%
23,400
– –
QUOT
1671
DELISTED
Quotient Technology Inc
QUOT
$113K ﹤0.01%
19,346
– –
TBPH icon
1672
Theravance Biopharma
TBPH
$878M
$100K ﹤0.01%
13,516
– –
GOTU icon
1673
Gaotu Techedu
GOTU
$408M
$95K ﹤0.01%
31,100
– –
PGEN icon
1674
Precigen
PGEN
$2.38B
$68K ﹤0.01%
13,604
– –
KPTI icon
1675
Karyopharm Therapeutics
KPTI
$44.2M
$61K ﹤0.01%
693
– –
65 66
67
68 69

Similar funds

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Handelsbanken Fonder's Q3 2021 Portfolio in Review

As of Q3 2021, Handelsbanken Fonder held 1,713 positions worth $19.1B, down 0.37% from $19.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 2.7%. Handelsbanken Fonder opened 9 new positions and exited 38, leaving the 1,713-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Handelsbanken Fonder's largest Q3 2021 buy was Volta Inc.: 1,671,677 shares worth $14.5M.
  • Handelsbanken Fonder added most to Regeneron Pharmaceuticals in Q3 2021, an estimated $83.2M increase.
  • Handelsbanken Fonder's biggest Q3 2021 reduction was Amgen, cutting an estimated $49.3M.
  • Handelsbanken Fonder fully exited Johnson Controls International in Q3 2021, selling an estimated $19.2M.
  • Handelsbanken Fonder's ten largest holdings make up 21% of its $19.1B portfolio in Q3 2021.
  • Handelsbanken Fonder opened 9 new positions and closed 38 in Q3 2021.
  • Handelsbanken Fonder's portfolio value fell 0.37% quarter-over-quarter to $19.1B.

Based on Handelsbanken Fonder's 13F filing for Q3 2021, filed 10 Nov 2021.